Rigel Pharmaceuticals
RIGL
RIGL
125 hedge funds and large institutions have $260M invested in Rigel Pharmaceuticals in 2025 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 45 increasing their positions, 36 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
4% more capital invested
Capital invested by funds: $250M → $260M (+$10.1M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.14% less ownership
Funds ownership: 77.84% → 77.7% (-0.14%)
Holders
125
Holding in Top 10
1
Calls
$975K
Puts
$2K
Top Buyers
| 1 | +$2.94M | |
| 2 | +$2.3M | |
| 3 | +$2.16M | |
| 4 |
LSV Asset Management
Chicago,
Illinois
|
+$1.79M |
| 5 |
Wells Fargo
San Francisco,
California
|
+$1.69M |
Top Sellers
| 1 | -$8.85M | |
| 2 | -$5.3M | |
| 3 | -$2.13M | |
| 4 |
Pacer Advisors
Malvern,
Pennsylvania
|
-$2.03M |
| 5 |
BlackRock
New York
|
-$2M |
